article · AIMS Medical Science
A study investigated the effectiveness of a honey-grape blend in reducing radiation oral mucositis (ROM) in 73 patients with locally advanced head and neck squamous cell carcinoma in Tanzania. ROM is a common and debilitating side effect of radiotherapy, impacting patients' quality of life and increasing treatment expenses. The cohort study, conducted from March to August 2024, used the World Health Organisation mucositis grading system to assess patient progress. Results showed that the honey-grape blend significantly delayed the onset and reduced the severity of ROM. Patients receiving the blend also experienced less weight loss compared to the control group. The findings suggest that honey and honey-grape blends could minimise and delay ROM, though further research is needed.
Radiation oral mucositis is a painful side effect of cancer treatment, severely affecting patients' ability to eat and their overall quality of life. Identifying natural, effective remedies like a honey-grape blend could significantly improve patient comfort and treatment adherence, making cancer therapy more tolerable.
This early-stage research indicates a potential natural intervention to alleviate radiation oral mucositis, a common and debilitating side effect for patients undergoing radiotherapy for head and neck cancer. Such a blend could be developed as a supportive care product to improve patient comfort and quality of life during treatment. Further clinical trials would be needed to validate its efficacy and safety for wider adoption.
AI-generated from the published abstract. Always read the original work before citing.
ObjectivesThis study assessed the efficacy of a honey–grape blend in reducing the severity and onset of radiation oral mucositis (ROM) in patients with locally advanced squamous cell carcinoma of the head and neck. Oral mucositis is an acute side effect caused by chemotherapy or radiotherapy in the head and neck region. ROM affects patients' quality of life and treatment expenses. Various pharmaceutical and natural remedies, such as sucralfate, aloe vera, and amifostine are used to mitigate the effects of ROM. However, the available modalities' efficacy is low and is associated with many side effects.Materials and methodsThis cohort study was conducted at the Ocean Road Cancer Institute and Besta Polyclinic in Tanzania. The study included 73 patients with locally advanced squamous cell carcinoma of the head and neck treated from March 2024 to August 2024. The World Health Organization mucositis grading system was used to assess patients' progress weekly. Data analysis was conducted using Statistical Package for Social Science (SPSS) version 27.ResultsDelayed onset (15% Grade 3 for the honey–grape group and 45% Grade 3 for the control group at 28 days) and reduced the severity of ROM (only 20% Grade 3 with no Grade 4 for the honey–grape group while for the control group, it was 25% Grade 3 and 20% Grade 4 at 45 days) (p-value < 0.001). Body weight changes at starting and after completion of radiotherapy were observed (2.65 kg average weight loss for the control group and 1.8 kg, 0.45 kg weight gain for the honey group and honey–grape blend group). Prevalence between genders was 62% males and 38% females.ConclusionsHoney and honey blended with grapes can minimize the severity and delay the onset of ROM in patients with locally advanced head and neck cancer. More studies are needed, since no study has been conducted addressing the efficacy of honey–grape blends in reducing ROM severity.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3934/medsci.2025007
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
